Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oral Health

Sec. Oral Infections and Microbes

Volume 6 - 2025 | doi: 10.3389/froh.2025.1661524

This article is part of the Research TopicDiagnosis and Therapeutic Interventions for Oral DiseasesView all 4 articles

Signs and symptoms of oral candidiasis associated with health factors and resistant Candida infections in a Northern Ontario patient cohort

Provisionally accepted
Karolina  CzajkaKarolina Czajka1*Chris  P VerschoorChris P Verschoor2,3,4,5Stacey  A SantiStacey A Santi2Danielle  Brabant-KirwanDanielle Brabant-Kirwan2Meredith  H KusnierczykMeredith H Kusnierczyk2Krishnan  VenkataramanKrishnan Venkataraman3,4Vasu  D AppannaVasu D Appanna4Ravi  SinghRavi Singh2,3Sujeenthar  TharmalingamSujeenthar Tharmalingam2,3,4Deborah  SaundersDeborah Saunders2,4*
  • 1Department of Psychiatry, Northern Ontario School of Medicine, Thunder Bay, ON, Canada
  • 2Health Sciences North Research Institute, Sudbury, Canada
  • 3NOSM University, Sudbury, Canada
  • 4Laurentian University School of Natural Sciences, Sudbury, Canada
  • 5McMaster University Department of Medicine, Hamilton, Canada

The final, formatted version of the article will be published soon.

Background: Oral candidiasis is a common fungal infection that disproportionately affects older adults, immunosuppressed individuals, and patients undergoing cancer treatment. Despite its prevalence, diagnosis and treatment remain challenging due to the diverse symptom presentation and potential for antifungal resistance.Objective: This study aimed to systematically evaluate which clinical signs and symptoms are most predictive of oral Candida infections, with a specific focus on identifying features associated with antifungal treatment failure. A secondary objective was to assess whether underlying medical conditions, including frailty and comorbidities, influence infection susceptibility or resolution following therapy.Methods: A cohort of 57 patients aged 65 years and older (mean age 74) was enrolled through oncology and hospitalist clinics in Northern Ontario. The majority (65%) were actively receiving cancer treatment. Participants underwent clinical assessment for oral candidiasis signs and symptoms, and fungal swabs were taken at baseline and two-week follow-up. Fungal species identification and treatment outcomes were recorded.The majority of infections involved Candida albicans and responded to standard antifungal treatment. In contrast, infections involving Nakaseomyces glabratus and Pichia kudriavzevii tended to persist, consistent with known antifungal resistance. Symptomatically, pseudomembranous candidiasis-characterized by white plaques, coated tongue, and taste disturbance-was more likely to resolve, while erythematous features such as angular cheilitis and oral redness were associated with persistent infection. Although 45% of patients were classified as moderately to severely frail, frailty status was not significantly associated with infection persistence or resistance.These findings underscore the clinical variability of oral candidiasis and highlight the need for rapid molecular diagnostic tools at the point of care to distinguish infection types and guide appropriate therapy, particularly in older and medically complex populations.

Keywords: Nakaseomyces glabratus, Pichia kudriavzevii, Candida albicans, antifungal resistance, oral candidiasis, older adults, Pseudomembranous candidiasis, Erythematous candidiasis

Received: 07 Jul 2025; Accepted: 25 Aug 2025.

Copyright: © 2025 Czajka, Verschoor, Santi, Brabant-Kirwan, Kusnierczyk, Venkataraman, Appanna, Singh, Tharmalingam and Saunders. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Karolina Czajka, Department of Psychiatry, Northern Ontario School of Medicine, Thunder Bay, ON, Canada
Deborah Saunders, Laurentian University School of Natural Sciences, Sudbury, Canada

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.